Madrigal Pharmaceuticals, Inc. company logo
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) Cash From Financing

Annual CFF

$735.06M$139.95M+23.52%

Summary

Current Value
As of today, MDGL annual cash from financing is $735.06M, up +23.52% on
Historical Performance
MDGL annual cash from financing is up +329.27% over the past 3 years, and up +312692.34% over the past 5 years
All-Time High Comparison
MDGL annual cash from financing is currently at its all-time high
3-Year Low Comparison
MDGL annual cash from financing is +134.51% above its 3-year low of $313.45M reached on an earlier date
Sector Comparison
MDGL annual cash from financing is higher than 98.30% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MDGL Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$735.06M+23.5%+329.3%+10000.0%+10000.0%
Quarterly Cash From Financing$236.65M+3071.4%+100.0%+10000.0%+1595.7%
TTM Cash From Financing$266.80M-77.7%+288.8%+10000.0%+572.4%
Price$505.23+84.3%+68.4%+343.2%+115.5%
Annual Cash From Operations-$455.57M-40.5%-147.7%-994.5%-1599.3%
Annual Cash From Investing-$274.39M+45.4%-5328.0%-993.6%-1403.6%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$119.57M+2.0%+10000.0%+10000.0%+5701.6%
Shares Outstanding22.71M+3.2%+25.5%+46.5%

Cash From Financing Highs

MDGL Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$735.06Mat high
5Y$735.06Mat high
All$735.06Mat high

Cash From Financing Lows

MDGL Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$313.45MN/A+134.5%
5Y$5.09MN/A>+9999.0%
All-$2.13M>+9999.0%

Cash From Financing History

YearValueChange
$735.06M+23.5%
$595.12M+89.9%
$313.45M+83.1%
$171.24M+3,265.5%
$5.09M+2,065.1%
$235.00K-99.9%
$314.34M+80.9%
$173.81M+1,102.5%
$14.45M+338.0%
$3.30M-96.1%
$85.30M+23.5%
YearValueChange
$69.04M-40.2%
$115.52M+214.4%
$36.74M-18.6%
$45.16M+2,221.0%
-$2.13M-11.7%
-$1.91M-104.3%
$43.88M+11.7%
$39.29M+939.7%
$3.78M-95.5%
$84.28M+18.5%
$71.12M-

FAQ

  • What is the current annual cash from financing of MDGL?

    As of today, MDGL annual cash from financing is $735.06M

  • What is 1-year change in MDGL annual cash from financing?

    MDGL annual cash from financing is up +23.52% year-over-year

  • What is 3-year change in MDGL annual cash from financing?

    MDGL annual cash from financing is up +329.27% over the past 3 years

  • How far is MDGL annual cash from financing from its all-time high?

    MDGL annual cash from financing is currently at its all-time high

  • How does MDGL annual cash from financing rank versus sector peers?

    MDGL annual cash from financing is higher than 98.30% of companies in Healthcare sector

  • When is MDGL next annual earnings release?

    The next annual earnings release for MDGL is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. MDGL Official Website www.madrigalpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
  4. MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
  5. MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl